184 related articles for article (PubMed ID: 30036530)
1. Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides.
Bazzazi H; Zhang Y; Jafarnejad M; Popel AS
J Theor Biol; 2018 Oct; 455():212-221. PubMed ID: 30036530
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
3. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
[TBL] [Abstract][Full Text] [Related]
4. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
5. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.
Gomez Perdiguero E; Liabotis-Fontugne A; Durand M; Faye C; Ricard-Blum S; Simonutti M; Augustin S; Robb BM; Paques M; Valenzuela DM; Murphy AJ; Yancopoulos GD; Thurston G; Galaup A; Monnot C; Germain S
J Pathol; 2016 Dec; 240(4):461-471. PubMed ID: 27577973
[TBL] [Abstract][Full Text] [Related]
7. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.
Lakshmikanthan S; Sobczak M; Chun C; Henschel A; Dargatz J; Ramchandran R; Chrzanowska-Wodnicka M
Blood; 2011 Aug; 118(7):2015-26. PubMed ID: 21636859
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.
Somanath PR; Malinin NL; Byzova TV
Angiogenesis; 2009; 12(2):177-85. PubMed ID: 19267251
[TBL] [Abstract][Full Text] [Related]
9. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
10. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.
Papo N; Silverman AP; Lahti JL; Cochran JR
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14067-72. PubMed ID: 21825147
[TBL] [Abstract][Full Text] [Related]
13. Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of αvβ3/VEGFR2 Axis.
Helal-Neto E; Brandão-Costa RM; Saldanha-Gama R; Ribeiro-Pereira C; Midlej V; Benchimol M; Morandi V; Barja-Fidalgo C
J Cell Physiol; 2016 Nov; 231(11):2464-73. PubMed ID: 27420801
[TBL] [Abstract][Full Text] [Related]
14. Involvement of αvβ3 integrin in gremlin-induced angiogenesis.
Ravelli C; Mitola S; Corsini M; Presta M
Angiogenesis; 2013 Jan; 16(1):235-43. PubMed ID: 23053782
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation controls cooperative PECAM-VEGFR2-β3 integrin functions at the endothelial surface for tumor angiogenesis.
Imamaki R; Ogawa K; Kizuka Y; Komi Y; Kojima S; Kotani N; Honke K; Honda T; Taniguchi N; Kitazume S
Oncogene; 2018 Aug; 37(31):4287-4299. PubMed ID: 29717262
[TBL] [Abstract][Full Text] [Related]
17. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α
Lamprou M; Kastana P; Kofina F; Tzoupis Η; Barmpoutsi S; Sajib MS; Koutsioumpa M; Poimenidi E; Zompra AA; Tassopoulos D; Choleva E; Tselios T; Mikelis CM; Papadimitriou E
Angiogenesis; 2020 Nov; 23(4):621-636. PubMed ID: 32681389
[TBL] [Abstract][Full Text] [Related]
18. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
[TBL] [Abstract][Full Text] [Related]
19. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS
Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795
[TBL] [Abstract][Full Text] [Related]
20. Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis.
Robinson SD; Reynolds LE; Kostourou V; Reynolds AR; da Silva RG; Tavora B; Baker M; Marshall JF; Hodivala-Dilke KM
J Biol Chem; 2009 Dec; 284(49):33966-81. PubMed ID: 19837659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
